Funding for this research was provided by:
Health and Labour Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labour and Welfare of Japan
Japan Society for the Promotion of Science (JSPS) KAKENHI (JP17J02428, JP18H02799)
Article History
Received: 5 November 2018
Accepted: 8 April 2019
First Online: 13 April 2019
Compliance with ethical Ssandards
:
: Nakase H has conflict of interest to Tanabe Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., Janssen Pharmaceutical K.K., Hoya Group Pentax Medical, Boehringer Ingelheim GmbH, and Daiichi Sankyo Company, Limited (to HN). All of them had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.